Peralta-Cuevas E, Garcia-Atutxa I, Huerta-Saquero A, Villanueva-Flores F
Viruses. 2025; 17(2).
PMID: 40006903
PMC: 11861432.
DOI: 10.3390/v17020148.
Celitan E, Staneviciene R, Serviene E, Serva S
Front Bioeng Biotechnol. 2024; 12:1456453.
PMID: 39386045
PMC: 11461329.
DOI: 10.3389/fbioe.2024.1456453.
Firdaus M, Mustopa A, Ekawati N, Chairunnisa S, Arifah R, Hertati A
J Genet Eng Biotechnol. 2023; 21(1):68.
PMID: 37222880
PMC: 10206359.
DOI: 10.1186/s43141-023-00514-9.
Schwestka J, Zeh L, Tschofen M, Schubert F, Arcalis E, Esteve-Gasent M
Front Plant Sci. 2023; 14:1109270.
PMID: 36733717
PMC: 9887037.
DOI: 10.3389/fpls.2023.1109270.
Jimenez-Cabello L, Utrilla-Trigo S, Barreiro-Pineiro N, Pose-Boirazian T, Martinez-Costas J, Marin-Lopez A
Vaccines (Basel). 2022; 10(7).
PMID: 35891288
PMC: 9319458.
DOI: 10.3390/vaccines10071124.
Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?.
Deshayes C, Gosselin-Grenet A, Ogliastro M, Lapied B, Apaire-Marchais V
Viruses. 2022; 14(5).
PMID: 35632685
PMC: 9144638.
DOI: 10.3390/v14050943.
Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production.
Monreal-Escalante E, Ramos-Vega A, Angulo C, Banuelos-Hernandez B
Vaccines (Basel). 2022; 10(1).
PMID: 35062761
PMC: 8782010.
DOI: 10.3390/vaccines10010100.
Microparticles and Nanoparticles from Plants-The Benefits of Bioencapsulation.
Schwestka J, Stoger E
Vaccines (Basel). 2021; 9(4).
PMID: 33920425
PMC: 8069552.
DOI: 10.3390/vaccines9040369.
Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.
Moradi Vahdat M, Hemmati F, Ghorbani A, Rutkowska D, Afsharifar A, Eskandari M
Biotechnol Rep (Amst). 2021; 29:e00605.
PMID: 33732633
PMC: 7937989.
DOI: 10.1016/j.btre.2021.e00605.
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
Nooraei S, Bahrulolum H, Hoseini Z, Katalani C, Hajizade A, Easton A
J Nanobiotechnology. 2021; 19(1):59.
PMID: 33632278
PMC: 7905985.
DOI: 10.1186/s12951-021-00806-7.
Current updates and research on plant-based vaccines for coronavirus disease 2019.
Uthaya Kumar A, Kadiresen K, Gan W, Ling A
Clin Exp Vaccine Res. 2021; 10(1):13-23.
PMID: 33628750
PMC: 7892944.
DOI: 10.7774/cevr.2021.10.1.13.
Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.
Sia Z, Miller M, Lovell J
Mol Pharm. 2020; 18(2):576-592.
PMID: 32787280
PMC: 8011859.
DOI: 10.1021/acs.molpharmaceut.0c00383.
Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M, Kouokam J
Viruses. 2020; 12(8).
PMID: 32751441
PMC: 7472025.
DOI: 10.3390/v12080826.
Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge.
Xie Y, Chang H, Li Z, Zhang Y
Front Microbiol. 2020; 11:1449.
PMID: 32733405
PMC: 7363769.
DOI: 10.3389/fmicb.2020.01449.
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production.
Shanmugaraj B, Bulaon C, Phoolcharoen W
Plants (Basel). 2020; 9(7).
PMID: 32635427
PMC: 7411908.
DOI: 10.3390/plants9070842.
Development of diagnostic tools for IBDV detection using plants as bioreactors.
Gomez E, Cassani M, Lucero M, Parreno V, Chimeno Zoth S, Berinstein A
AMB Express. 2020; 10(1):95.
PMID: 32436057
PMC: 7239984.
DOI: 10.1186/s13568-020-01029-z.
A multi-epitope plant-made chimeric protein (LTBentero) targeting common enteric pathogens is immunogenic in mice.
Trujillo E, Rosales-Mendoza S, Angulo C
Plant Mol Biol. 2019; 102(1-2):159-169.
PMID: 31820286
PMC: 7223238.
DOI: 10.1007/s11103-019-00938-3.
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins.
Jazayeri S, Poh C
Vaccines (Basel). 2019; 7(4).
PMID: 31683888
PMC: 6963725.
DOI: 10.3390/vaccines7040169.
Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C, Beiss V, Steinmetz N
J Virol. 2019; 93(21).
PMID: 31375592
PMC: 6803287.
DOI: 10.1128/JVI.00129-19.
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages.
Makarkov A, Golizeh M, Ruiz-Lancheros E, Gopal A, Costas-Cancelas I, Chierzi S
NPJ Vaccines. 2019; 4:17.
PMID: 31123605
PMC: 6520342.
DOI: 10.1038/s41541-019-0111-y.